X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Indian stock markets open flat 
(Tue, 9 Dec 09:30 am) 
 
Asian stock markets have opened on a mixed note with stock markets in China up 1.2% and Japan down 0.3%. The Indian stock markets have opened the day on a flat note. The stocks from power and metal sector were leading the losses while stocks in the software and pharma sector were trading firm.

The Sensex today is down by around 20 points, while the NSE-Nifty is down by about 16 points. The mid cap and small cap stocks have also opened flat with BSE Mid Cap index and BSE Small Cap index up by around 0.1% each. The rupee is currently trading at Rs 61.92 to the US dollar.

Indian pharma stocks have opened the day positive note. As per the financial daily, the competition commission of India (CCI) has finally cleared US $ 4 bn deal between Sun pharmaceuticals and Ranbaxy laboratories. However the regulator has put some conditions to it. The CCI has asked both the companies to sell 7 brands which could have adverse effect on the competition, post merger. Consequently, the regulator has given 6 months time for the divestment process. The 7 brands that are supposed to be divested are of less than Rs 500 m. Among these 7 products, Sun has to divest a product, Tamsulosin Plus Tolterodine which is worth Rs 30 m. While, Ranbaxy has to divest 6 brands worth Rs 300 m, the biggest brand among these is Eligard. In all these brands the companies have market share of above 50-60%, and thus CCI has directed to divest them. Since these brands have good market share, we expect both the companies will be able to sell them at premium valuations.

Automobile stocks have opened the day mixed note. As per a leading financial daily, Tata motors has launched a variant of its leading selling brand, Jaguar land rover (JLR) - Jaguar XF. The car is priced at Rs 45.12 lakhs (ex-showroom). The Executive Edition of Jaguar XF is powered by a 2.2 litre diesel engine and comes with a range of features including eight speed automatic transmission and navigation system. As per the vice president Rohit Suri, the new brand will give access to wider audience. Tata Motors has opened up by 0.5%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Indian stock markets open flat". Click here!

  
 

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE AUTO


Aug 18, 2017 (Close)

S&P BSE AUTO 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS